In lung adenocarcinoma (LUAD) and epithelial ovarian cancer (EOC), it has been suggested that BTN3A2 expression was positively correlated with CD4+ T cell, neutrophil, B cell, and macrophage infiltration to the tumor area [20,45]. This evidence concerns the gene BTN3A2 and ovarian carcinoma.